A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS)
Clinical trial NCT03239600 · WITHDRAWN
Trial details
- NCT number
- NCT03239600
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2017-10-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.